Skip to Main Content

Paper Details

Relapsed or refractory large B-cell lymphoma after chimeric antigen receptor T-cell therapy: Current challenges and therapeutic options.
Br J Haematol
4
2023
Author NameAffiliation
Adetola A KassimVanderbilt University Medical Center
  • 1 - 1

Datasets

Release 1.2